PAXBP1 is an adapter protein that links the transcription factors PAX3 and PAX7 to histone methylation machinery, playing a critical role in myogenesis and skeletal muscle development 1. The protein recruits histone methyltransferase complexes to mediate dimethylation and trimethylation of histone H3 lysine 4, regulating expression of genes essential for muscle progenitor cell proliferation, including ID3 and CDC20 1. PAXBP1 is highly expressed in brain cerebellar regions and muscle precursor cells 1, and its core promoter contains an exceptionally expanded and conserved CT-repeat complex unique to primates, suggesting evolutionary significance in primate craniofacial development and myogenesis 2. Pathologically, homozygous missense variants in PAXBP1 cause global developmental delay and myopathic hypotonia 1. The p.Arg538Cys mutation disrupts the PAX7 binding domain, preventing critical hydrogen bonding and impairing protein function 1. PAXBP1 dysregulation occurs in multiple disease contexts: it is dysregulated in cancer and dermatomyositis through ncRNA interactions 3, and differential expression in immune cells correlates with COVID-19 disease severity 4. Additionally, PAXBP1 over-expression in Down syndrome models suggests involvement in interferon-related pathways disrupted in neurodevelopmental disease 5.